Evidence map›Paper›PMID 38105675›Full record

ArticleZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2023

A case of

Lihua Wu, Tinghua Ye, Xinling Pan, Li Hong, Yunzhen Shi

Open access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 86% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lihua WuDepartment of Infectious disease, Dongyang People's Hospital, Dongyang 322100, Zhejiang Province, China. weizhenbafang29@163.com.
Tinghua YeClinical Laboratory, Dongyang People's Hospital, Dongyang 322100, Zhejiang Province, China.
Xinling PanDepartment of Biological Laboratory, Dongyang People's Hospital, Dongyang 322100, Zhejiang Province, China.
Li HongDepartment of Infectious disease, Dongyang People's Hospital, Dongyang 322100, Zhejiang Province, China.
Yunzhen ShiDepartment of Infectious disease, Dongyang People's Hospital, Dongyang 322100, Zhejiang Province, China. syzwylwmc@163.com.
Wenzhou Medical University · CNDongyang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 82-year-old man was admitted to hospital with fever, unresponsiveness, elevated hypersensitive C-reactive protein and neutrophile granulocyte. Ceftriaxone was administrated by intravenous dripping in the emergency room, but the effect was not satisfactory. Following his admission to the ward, cefoperazone sulbactam were given.

Indexed as

Flavobacteriaceae InfectionsSepsisAged, 80 and overCefoperazoneC-Reactive ProteinHumansMaleRNA, Ribosomal, 16SSulbactamCefoperazoneC-Reactive ProteinRNA, Ribosomal, 16SSulbactamCase reportCefoperazone sulbactamElizabethella spp.Elizabethkingia meningosepticaGene sequencingLevofloxacinSepticaemia

Identifiers

PMID38105675
PMCPMC10945492
OpenAlexW4389623226

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.